CSBR שולי רווח נקי Champions Oncology Inc

Champions Oncology generates revenue by conducting personalized drug tests using unique tumor models. The net profit margin illustrates cost efficiency dynamics, where the value of -1.80 reflects this status. Strong pricing power over the pharmaceutical market and a transition to a SaaS model for predictive data analysis provide the company with significant potential for business scaling.
פילוחי מדדים מקיפים ואנליטיקה עבור Champions Oncology, Inc. (CSBR)

For Champions Oncology (CSBR), the efficiency of developing personalized tumor models directly impacts profitability. This metric measures the share of net profit within total revenue, demonstrating the final yield of each unit of services sold. By analyzing the net operating margin, an investor assesses the business's ability to convert innovation into actual cash flow. The net operating margin trend reveals the model's resilience to operating expenses, allowing for the determination of the true financial value of this high-tech medical service.